Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

SASLT practice guidelines: management of hepatitis C virus infection.

Alghamdi AS, Sanai FM, Ismail M, Alghamdi H, Alswat K, Alqutub A, Altraif I, Shah H, Alfaleh FZ; Saudi Association for the Study of Liver Diseases and Transplantation.

Saudi J Gastroenterol. 2012 Sep;18 Suppl:S1-32. No abstract available.

2.

Molecular and contextual markers of hepatitis C virus and drug abuse.

Shapshak P, Somboonwit C, Drumright LN, Frost SD, Commins D, Tellinghuisen TL, Scott WK, Duncan R, McCoy C, Page JB, Giunta B, Fernandez F, Singer E, Levine A, Minagar A, Oluwadara O, Kotila T, Chiappelli F, Sinnott JT.

Mol Diagn Ther. 2009;13(3):153-79. doi: 10.2165/01250444-200913030-00002. Review.

3.

Modeling hepatitis C virus dynamics: liver regeneration and critical drug efficacy.

Dahari H, Lo A, Ribeiro RM, Perelson AS.

J Theor Biol. 2007 Jul 21;247(2):371-81. Epub 2007 Mar 14.

4.

Novel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patients.

Fabrizi F, Lunghi G, Aucella F, Mangano S, Barbisoni F, Bisegna S, Vigilante D, Limido A, Martin P.

J Clin Microbiol. 2005 Jan;43(1):414-20.

5.

Expertise of French laboratories in detection, genotyping, and quantification of hepatitis C virus RNA in serum.

Lefrère JJ, Roudot-Thoraval F, Lunel F, Alain S, Chaix ML, Dussaix E, Gassin M, Izopet J, Pawlotsky JM, Payan C, Stoll-Keller F, Thibault V, Trabaud MA, Bettinger D, Bogard M, Branger M, Buffet-Janvresse C, Charrois A, Defer C, Laffont C, Lerable J, Levayer T, Martinot-Peignoux M, Mercier B, Rosenberg AR.

J Clin Microbiol. 2004 May;42(5):2027-30.

8.

Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients.

Hinrichsen H, Leimenstoll G, Stegen G, Schrader H, Fölsch UR, Schmidt WE; PHV Study Group.

Gut. 2002 Sep;51(3):429-33.

9.

Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA.

Giachetti C, Linnen JM, Kolk DP, Dockter J, Gillotte-Taylor K, Park M, Ho-Sing-Loy M, McCormick MK, Mimms LT, McDonough SH.

J Clin Microbiol. 2002 Jul;40(7):2408-19.

11.

Risk and management of blood-borne infections in health care workers.

Beltrami EM, Williams IT, Shapiro CN, Chamberland ME.

Clin Microbiol Rev. 2000 Jul;13(3):385-407. Review.

12.

Assessment of viral loads in patients with chronic hepatitis C with AMPLICOR HCV MONITOR version 1.0, COBAS HCV MONITOR version 2.0, and QUANTIPLEX HCV RNA version 2.0 assays.

Martinot-Peignoux M, Le Breton V, Fritsch S, Le Guludec G, Labouret N, Keller F, Marcellin P.

J Clin Microbiol. 2000 Jul;38(7):2722-5.

13.

Performance of the COBAS AMPLICOR HCV MONITOR test, version 2.0, an automated reverse transcription-PCR quantitative system for hepatitis C virus load determination.

Gerken G, Rothaar T, Rumi MG, Soffredini R, Trippler M, Blunk MJ, Butcher A, Soviero S, Colucci G.

J Clin Microbiol. 2000 Jun;38(6):2210-4.

14.

Hepatitis C virus quantitation: optimization of strategies for detecting low-level viremia.

Hofgärtner WT, Kant JA, Weck KE.

J Clin Microbiol. 2000 Feb;38(2):888-91.

15.

Effect of retreatment with interferon alone or interferon plus ribavirin on hepatitis C virus quasispecies diversification in nonresponder patients with chronic hepatitis C.

Gerotto M, Sullivan DG, Polyak SJ, Chemello L, Cavalletto L, Pontisso P, Alberti A, Gretch DR.

J Virol. 1999 Sep;73(9):7241-7.

17.

Serum and liver HCV RNA levels in patients with chronic hepatitis C: correlation with clinical and histological features.

De Moliner L, Pontisso P, De Salvo GL, Cavalletto L, Chemello L, Alberti A.

Gut. 1998 Jun;42(6):856-60.

18.

Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection.

Polyak SJ, McArdle S, Liu SL, Sullivan DG, Chung M, Hofgärtner WT, Carithers RL Jr, McMahon BJ, Mullins JI, Corey L, Gretch DR.

J Virol. 1998 May;72(5):4288-96.

19.

Comparison of a competitive combined reverse transcription-PCR assay with a branched-DNA assay for hepatitis C virus RNA quantitation.

Mayerat C, Bürgisser P, Lavanchy D, Mantegani A, Frei PC.

J Clin Microbiol. 1996 Nov;34(11):2702-6.

20.

Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients.

Gretch DR, Polyak SJ, Wilson JJ, Carithers RL Jr, Perkins JD, Corey L.

J Virol. 1996 Nov;70(11):7622-31.

Supplemental Content

Support Center